Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize ...
As the popularity of GLP-1 meds like Wegovy and Zepbound grows, fewer Americans are turning to weight-loss surgeries to trim ...
An investigational antibody demonstrated an ability to preserve vision in people with geographic atrophy from dry age-related ...
Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...
Preliminary data from a late stage clinical trial of a retinal implant showed promising results, Science Corporation said ...
CHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...
Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Novo Nordisk asked the FDA to bar compounding pharmacies from making semaglutide, arguing it is too complex for the ...
Age-related macular degeneration (AMD) is one of the leading causes of vision ... Given the increasing number of people at risk, the potential for using such a well-known, safe treatment could have an ...
Dr Arshad Khanani anticipates presentations offering new strategies to tackle challenges such as macular atrophy and fibrosis, and optimizing dosing intervals in wet AMD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback